On October 20, Sansure Biotech disclosed 2022 third quarter report, the company achieved revenue of CNY 4.068 billion in three quarters this year, an increase of 24.52% year-on-year; the net profit attributable to the mother achieved CNY 1.598 billion.
Oxford Nanopore Technologies reported on Tuesday morning that its revenues in the first half of 2022 more than doubled year over year, driven by COVID-19 testing.
Biocartis on Thursday reported a 21 percent year-over-year increase in revenues for the first half of 2022 as higher collaboration revenue offset a decline in SARS-CoV-2 product sales.
Burning Rock Biotech said Wednesday that its second quarter revenues were up about 3 percent year over year.
On August 26, Dian Diagnostics achieved operating income of CNY 10.753 billion, an increase of 85.68% over the same period last year; net profit attributable to the parent was CNY 1.880 billion, an increase of 158.54% over the same period last year.
In the first half of 2022, among the four major business lines of the company, the infectious disease business income reached 3.207 billion CNY, a significant increase of 240.32% over the same period of last year.
On August 17, AutoBio Diagnostics released its first-half results of 2022. The company achieved CNY 2.070 billion revenue by the end of June, with a year-on-year increase of 23.41%. The net profit attributable to shareholders was CNY 534 million, increasing 29.28% than the last year.
Ginkgo Bioworks reported after the close of the market on Monday that its second quarter 2022 revenues grew 231 percent year over year, driven by biosecurity service revenues.
QuidelOrtho reported after the close of the market Thursday that its second quarter revenues rose 38 percent year over year, which the firm attributed in part to growth in its point-of-care and molecular diagnostics businesses.
Meridian Bioscience reported on Friday morning a 7 percent year-over-year increase in its fiscal third quarter revenues, one month after announcing it will be acquired by a newly formed affiliate of SD Biosensor and SJL Partners.
✔ All (240)
✔ Press release (0)
✔ Industry news (240)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.